QF
MRTX

QVT Financial’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

QVT Financial’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-509,750
Closed -$2.78M – 78
2016
Q2 		$2.78M Sell
509,750
-48,875
-9% -$779K 0.19% 66
2016
Q1 		$12M Buy
558,625
+307,488
+122% +$6.88M 0.73% 37
2015
Q4 		$7.94M Sell
251,137
-26,596
-10% -$939K 0.45% 56
2015
Q3 		$9.56M Sell
277,733
-14,789
-5% -$447K 0.33% 51
2015
Q2 		$9.21M Sell
292,522
-163,944
-36% -$4.83M 0.14% 65
2015
Q1 		$13.4M Sell
456,466
-50,718
-10% -$1.19M 0.75% 38
2014
Q4 		$8.58M Hold
507,184
– – 0.43% 56
2014
Q3 		$8.57M Hold
507,184
– – 0.44% 53
2014
Q2 		$9.95M Sell
507,184
-26,694
-5% -$515K 0.54% 54
2014
Q1 		$10.2M Sell
533,878
-7,100
-1% -$148K 0.58% 54
2013
Q4 		$8.24M Sell
540,978
-52,000
-9% -$889K 0.48% 56
2013
Q3 		$6.79M Buy
+592,978
New +$5.83M 0.46% 53

Other funds holding MRTX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

QVT Financial's MRTX Position: Q3 2016 in Review

QVT Financial sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q3 2016, closing a stake of 509,750 shares — an estimated $2.78M sold.

QVT Financial first reported a position in MRTX in Q3 2013 and held it in 12 quarters. The position peaked at $13.4M in Q1 2015. 69 funds tracked by Wall St. Rank hold MRTX as of Q3 2016.

  • QVT Financial reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • QVT Financial sold 509,750 Mirati Therapeutics, Inc. Common Stock shares in Q3 2016, an estimated $2.78M.
  • QVT Financial first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2013 and held it in 12 quarters.
  • QVT Financial's Mirati Therapeutics, Inc. Common Stock position peaked at $13.4M in Q1 2015.
  • 69 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q3 2016.

Based on QVT Financial's 13F filing for Q3 2016, filed 14 Nov 2016.